Scott D Morenstein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott D Morenstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott D Morenstein. Scott D Morenstein is Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Molecular Templates, Inc. ($THLD) and Director in Celator Pharmaceuticals Inc ($CPXX).
Latest Insider Trading Transactions of Scott D Morenstein
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CPXX, SNTA, MTEM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2020 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 15.43 | 15,000 | 231,450 | 15,000 | |
Nov 25 2019 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Buy | P | 8.00 | 468,750 | 3,750,000 | 2,052,991 | 1.6 M to 2.1 M (+29.59 %) |
May 30 2019 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
Sep 27 2018 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Buy | P | 5.50 | 545,454 | 2,999,997 | 1,559,241 | 1 M to 1.6 M (+53.80 %) |
Oct 11 2017 | THLD | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | U | 3.58 | 314,611 | 1,126,307 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 3.58 | 358 | 1,282 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 3.12 | 28,000 | 87,248 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 2.80 | 14,000 | 39,200 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | D | 2.60 | 14,000 | 36,400 | 0 | |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | U | 30.25 | 1,039,109 | 31,433,047 | 0 | 1 M to 0 (-100.00 %) |
Jul 12 2016 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | D | 30.25 | 6,277 | 189,879 | 0 | 6.3 K to 0 (-100.00 %) |
Jan 05 2016 | SNTA | SYNTA PHARMACEUTIC ... | Morenstein Scott D | Director | Grant | A | 0.00 | 17,857 | 0 | 17,857 | 0 to 17.9 K |
Dec 07 2015 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Buy | P | 1.87 | 5,000 | 9,325 | 6,277 | 1.3 K to 6.3 K (+391.54 %) |
Nov 05 2015 | SNTA | SYNTA PHARMACEUTIC ... | Morenstein Scott D | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
Jun 15 2015 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | A | 2.60 | 14,000 | 36,400 | 14,000 |
Page: 1